5,7-difluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline

Catalog No.: 
ACLACQ038
CAS No.: 
2052166-01-3
Molecular Formula: 
C15H16BF2NO2
Molecular Weight: 
291.11
5,7-difluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$338.00InquiryInquiry
250mg98%$540.00InquiryInquiry
1g98%$1351.00InquiryInquiry
5g98%$4051.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,7-difluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline
IUPAC Name5,7-difluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline
Molecular FormulaC15H16BF2NO2
Molecular Weight291.11
SMILESCC1(C)OB(C2=C(F)C=C3N=CC=CC3=C2F)OC1(C)C
InChI KeyZYXNIEDHKXJVTO-UHFFFAOYSA-N
SynonymQuinoline, 5,7-difluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.2052166-01-3

Synthetic Route by SureRoute

1. ACLACQ038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. ACTJMI139 route compound structure diagram
    ACTJMI1391022091-49-1In Stock
  4. Then
  5. ACLACQ038 route product structure diagram
    ACLACQ0382052166-01-3
Inquiry

2. ACLACQ038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLACQ038 route product structure diagram
    ACLACQ0382052166-01-3
Inquiry

3. ACLACQ038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLACQ038 route product structure diagram
    ACLACQ0382052166-01-3
Inquiry

Comments (0)